eznews.inA recent systematic review and meta-analysis published in *Nutrients* has highlighted a concerning link between skipping breakfast and an increased risk of metabolic syndrome, a cluster of conditions including high blood pressure and obesity that can lead to serious health issues like heart disease and diabetes. Researchers analyzed data from nine studies involving over 118,000 participants, concluding that breakfast omission is associated with higher risks of abdominal obesity, high blood pressure, and elevated blood sugar levels. While the findings suggest that regular breakfast consumption may play a crucial role in metabolic health, experts caution that the observational nature of the studies limits definitive causation conclusions. They emphasize the importance of a balanced diet and healthy lifestyle choices alongside regular meal patterns for optimal metabolic function. The study underscores the potential health benefits of what is often dubbed "the most important meal of the day." 
Published: Oct 20 2025, 10 pmeznews.inExperts are warning against the use of leftover medication, termed the "golden dose," in GLP-1 injection pens like Mounjaro and Ozempic, designed for diabetes treatment and weight loss. Many users notice a small amount of medication remains after the prescribed four doses, prompting curiosity about its safety. However, medical professionals emphasize that this leftover liquid is not a bonus dose but rather a deliberate overfill for priming the pen. Utilizing this excess can lead to serious risks, including inaccurate dosing and potential contamination. Eli Lilly, the manufacturer of Mounjaro, is reportedly redesigning its injector pens to eliminate this extra liquid. Experts recommend proper disposal of used pens in a sharps container after the four doses are administered, and advise users to consult healthcare professionals for any dosing concerns, stressing that safety should always come first when using these medications.
Published: Oct 20 2025, 6 pmeznews.inRecent research has raised concerns about the potential health risks associated with artificial sweeteners, particularly their impact on cognitive function. A study published in *Neurology* linked sweeteners such as aspartame and erythritol to cognitive declines equivalent to about 1.6 years of brain aging. While these sugar alternatives are widely consumed—especially among diabetics seeking to avoid blood sugar spikes—the Food and Drug Administration (FDA) has deemed several, including saccharin and sucralose, safe for consumption. However, the growing body of research on their long-term effects has prompted discussions among health experts. Claudia Suemoto, a physician and senior author of the study, highlighted these concerns in a recent podcast, emphasizing the need for further investigation into how artificial sweeteners may affect brain health and overall well-being. As the debate continues, consumers are left questioning the safety of these popular substitutes.
Published: Oct 19 2025, 1 pmeznews.inA recent study has reinforced the link between cholesterol levels and dementia risk, suggesting that lowering cholesterol could significantly reduce the likelihood of developing the condition. With over 55 million people living with dementia globally in 2020—a number projected to rise to 78 million by 2030—researchers found that individuals with genetic variants leading to lower cholesterol had a reduced risk of dementia. For those without these variants, cholesterol-lowering medications, such as statins, could yield similar protective effects. The study highlighted that even a modest reduction in cholesterol levels could cut dementia risk by up to 80%. Experts emphasize the importance of early intervention in managing cholesterol to potentially prevent dementia, as current treatment options remain limited. This research underscores the need to address cardiovascular risk factors not only for heart health but also for cognitive well-being, offering hope for new preventative strategies against dementia.
Published: Oct 18 2025, 11 ameznews.inNew guidelines from the British Dietetic Association (BDA) recommend dietary interventions to alleviate chronic constipation, which affects up to 20% of adults in the U.S. The guidelines, developed after analyzing 75 clinical trials, suggest that consuming two to three kiwifruits daily, along with high mineral-content water and rye bread, can significantly improve bowel health. Kiwifruit, noted for its high fiber content and the enzyme actinidin, is particularly effective in increasing stool frequency. The BDA emphasizes the importance of evidence-based recommendations, having established 59 statements on dietary approaches, while advising against reliance on probiotics and senna supplements due to limited efficacy. Experts in the field have praised the guidelines for providing clear, actionable advice, moving beyond generic recommendations to specific foods and strategies, thus empowering individuals to manage their symptoms effectively.
Published: Oct 18 2025, 12 ameznews.inAs the Medicare open enrollment period unfolds, experts emphasize the importance for beneficiaries to evaluate their coverage options for 2026, amid anticipated changes in costs and services. Monthly premiums for Medicare Part B are expected to rise by 12% from $185 to $206, while some Medicare Advantage plans may see a decrease in premiums from $16 to $14. Additionally, the annual deductible for Part B is projected to increase by 12% to $288. There are concerns regarding the impact of a potential government shutdown on claims processing and telehealth services, which could further complicate access to care for vulnerable populations. With around 69 million Americans relying on Medicare, experts warn that many recipients do not currently compare plans, potentially missing out on savings. Whitney Stidom of eHealth advises beneficiaries to utilize resources to explore their options thoroughly during this critical enrollment period.
Published: Oct 17 2025, 9 pmeznews.inA recent study suggests that two widely used heart medications, pemafibrate and telmisartan, may reverse fatty liver disease, known as metabolic dysfunction-associated steatotic liver disease (MASLD), in animal models. MASLD affects nearly 40% of adults globally and can progress to severe liver conditions if untreated. The research, published in *Pharmacological Research*, found that both drugs significantly reduced fat accumulation in the liver of rats and zebrafish larvae, with a combination of the two proving as effective as higher doses of each individually. The study's lead author, Marta Alegret, emphasized the importance of further clinical trials to validate these findings in humans before recommending their use for treating MASLD. Experts highlight the potential benefits of repurposing existing medications, given their established safety profiles, to address this growing health concern.
Published: Oct 16 2025, 1 pmeznews.inA recent study published in *The Lancet Healthy Longevity* has revealed that quitting smoking, even in midlife or later, can significantly slow down age-related cognitive decline. Researchers analyzed data from 4,718 adults aged 40 to 89 who quit smoking, comparing them to an equal number of ongoing smokers. Findings indicated that those who quit experienced a 20% slower rate of memory decline and a 50% slower decline in verbal fluency. Lead author Mikaela Bloomberg, a senior research fellow at University College London, emphasized the importance of cessation efforts for older adults, who are at the highest risk from smoking. While the study strengthens the case for quitting smoking as a means to protect cognitive health, Bloomberg cautioned that further research is needed to explore the potential links to dementia and the biological mechanisms involved. Experts highlight the study's implications for older smokers, suggesting that quitting could be a vital strategy for maintaining cognitive health.
Published: Oct 15 2025, 5 pmeznews.inA recent study presented at the 2025 ECNP Congress has revealed that different types of depression are linked to varying risks of cardiometabolic diseases, including type 2 diabetes and cardiovascular issues. Researchers tracked over 5,700 adults for seven years, finding that those with atypical depression symptoms—characterized by fatigue and increased appetite—were 2.7 times more likely to develop type 2 diabetes. Conversely, participants exhibiting melancholic symptoms, such as insomnia and low appetite, had a 1.5 times greater chance of developing cardiovascular disease. The study, co-led by Dr. Yuri Milaneschi, highlights the complex relationship between mental health and physical well-being, suggesting that distinct biological mechanisms may underlie these associations. Experts emphasize the need for further research to explore these links and develop targeted treatments, as understanding the interplay between depression and metabolic disorders could improve patient outcomes significantly.
Published: Oct 14 2025, 9 pmeznews.inResearchers at the University of East Anglia and Oxford Biodynamics have developed a promising blood test that could revolutionize the diagnosis of chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME). This new test boasts a remarkable 96% accuracy rate, addressing the longstanding challenge of diagnosing a condition often confused with other disorders like fibromyalgia and multiple sclerosis. Currently, CFS lacks a definitive diagnostic test, relying instead on symptom checklists and the exclusion of other diseases. The test examines unique DNA folding patterns in patients, revealing a distinct biological signature absent in healthy individuals. Lead researcher Dmitry Pshezhetskiy emphasized that this advancement could not only streamline diagnosis but also pave the way for targeted therapies. While experts acknowledge the need for further studies to validate the test's effectiveness across broader populations, they express optimism about its potential to provide clarity and support for patients enduring debilitating symptoms.
Published: Oct 13 2025, 10 pmFor the fastest, latest, not so wokest news, 'experts say' you need to visit Eznews
India
World
Economy
Science
Health
Showbiz
Contact